| Unbound MEDLINE results for: | Bookmark this site | | Articles related to 10827390 [Unique ID], provided by the PubMed system | |
| |
|
| | 1 - 10 of 153 journal articles in the PubMed database | Email to a friend | | |
| Kitzman DW, Wesley DJ
Safety assessment of perflenapent emulsion for echocardiographic contrast enhancement in patients with congestive heart failure or chronic obstructive pulmonary disease. [Clinical Trial, Clinical Trial, Phase II, Journal Article, Multicenter Study, Randomized Controlled Trial]
Am Heart J 2000 Jun; 139(6):1077-80.
Abstract | Full Citation | Find Related Articles | | Quay SC, Eisenfeld AJ
Safety assessment of the use of perflenapent emulsion for contrast enhancement of echocardiography and diagnostic radiology ultrasound studies. [Journal Article]
Clin Cardiol 1997 Oct; 20(10 Suppl 1):I19-26.
Abstract | Full Citation | Find Related Articles | | Robbin ML, Eisenfeld AJ
Perflenapent emulsion: a US contrast agent for diagnostic radiology--multicenter, double-blind comparison with a placebo. EchoGen Contrast Ultrasound Study Group. [Clinical Trial, Clinical Trial, Phase III, Comparative Study, Journal Article, Multicenter Study, Randomized Controlled Trial, Research Support, Non-U.S. Gov't]
Radiology 1998 Jun; 207(3):717-22.
Abstract | Full Citation | Find Related Articles | | Cohen JL, Cheirif J, Segar DS, et al.
Improved left ventricular endocardial border delineation and opacification with OPTISON (FS069), a new echocardiographic contrast agent. Results of a phase III Multicenter Trial. [Clinical Trial, Clinical Trial, Phase III, Journal Article, Multicenter Study]
J Am Coll Cardiol 1998 Sep; 32(3):746-52.
Abstract | Full Citation | Publisher Full Text | Find Related Articles | | Kitzman DW, Goldman ME, Gillam LD, et al.
Efficacy and safety of the novel ultrasound contrast agent perflutren (definity) in patients with suboptimal baseline left ventricular echocardiographic images. [Clinical Trial, Journal Article, Multicenter Study, Randomized Controlled Trial]
Am J Cardiol 2000 Sep 15; 86(6):669-74.
Abstract | Full Citation | Publisher Full Text | Find Related Articles | | Grayburn PA, Weiss JL, Hack TC, et al.
Phase III multicenter trial comparing the efficacy of 2% dodecafluoropentane emulsion (EchoGen) and sonicated 5% human albumin (Albunex) as ultrasound contrast agents in patients with suboptimal echocardiograms. [Clinical Trial, Clinical Trial, Phase III, Journal Article, Multicenter Study]
J Am Coll Cardiol 1998 Jul; 32(1):230-6.
Abstract | Full Citation | Find Related Articles | | Grayburn P
Perflenapent emulsion (EchoGen): a new long-acting phase-shift agent for contrast echocardiography. [Journal Article, Review]
Clin Cardiol 1997 Oct; 20(10 Suppl 1):I12-8.
Abstract | Full Citation | Find Related Articles | | Bokor D, Chambers JB, Rees PJ, et al.
Clinical safety of SonoVue, a new contrast agent for ultrasound imaging, in healthy volunteers and in patients with chronic obstructive pulmonary disease. [Clinical Trial, Clinical Trial, Phase II, Journal Article, Randomized Controlled Trial]
Invest Radiol 2001 Feb; 36(2):104-9.
Abstract | Full Citation | Find Related Articles | | Olszewski R, Marciniak W, Nowicki A, et al.
[The improvement of echocardiographic assessment of the left ventricle by the use of perflenapent and harmonic imaging] [Comparative Study, English Abstract, Journal Article]
Pol Merkur Lekarski 1998 Sep; 5(27):132-4.
Abstract | Full Citation | Publisher Full Text | Find Related Articles |   |
|
| |
Advertise on this site.
|
